Top Markets
#1 Islamic Coin Islamic Coin +151.26%
#2 Akedo Akedo +76.66%
#3 Velvet Velvet +52.20%
#4 Glidr Glidr +51.75%
#5 DOVU DOVU +48.24%
#6 Black Phoenix Black Phoenix +33.87%
#7 Cross Cross +32.61%
#8 Cap Cap +20.07%
#9 DoubleZero DoubleZero +16.25%
#10 Movement Movement +9.75%
Coin of the day
Islamic Coin Islamic Coin
Настройки
Язык
Pусский
Валюта
USD
Тема
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

HEPA
Ранг среди акций #39072
Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is... Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials. This compound operates by disrupting multiple pathological pathways implicated in the worsening of liver disease. It is currently progressing through clinical development for non-alcoholic steatohepatitis (NASH) and is additionally being explored in nonclinical research for its potential to reduce liver fibrosis and lessen hepatocellular carcinoma tumor loads in experimental models of NASH. Moreover, Rencofilstat has exhibited antiviral properties against hepatitis B, C, and D viruses through diverse mechanisms. The company, established in 2013 and situated in Edison, New Jersey, rebranded as Hepion Pharmaceuticals, Inc. in July 2019, having previously operated as ContraVir Pharmaceuticals, Inc.
Цена акции
$0.0568
Последняя синхронизация: 2026-08-13
Рыночная капитализация
$661.36K
Изменение (1 день)
11.37%
Изменение (1 год)
-5.33%
Страна
US
Торговля Hepion Pharmaceuticals, Inc. (HEPA)

Категория

Healthcare
Коэффициент P/B для Hepion Pharmaceuticals, Inc. (HEPA)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Hepion Pharmaceuticals, Inc., текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Hepion Pharmaceuticals, Inc. с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE